These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2479162)

  • 1. Effects of experimental recombinant interferons on multiple sclerosis.
    Johnson KP; Panitch HS
    Trans Am Clin Climatol Assoc; 1989; 100():171-6. PubMed ID: 2479162
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interferons: biological effects, mechanisms of action, and use in multiple sclerosis.
    Weinstock-Guttman B; Ransohoff RM; Kinkel RP; Rudick RA
    Ann Neurol; 1995 Jan; 37(1):7-15. PubMed ID: 7529476
    [No Abstract]   [Full Text] [Related]  

  • 4. New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.
    Stone I
    Australas Nurses J; 1982 Apr; 11(3):13-5. PubMed ID: 6180724
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon therapy for multiple sclerosis.
    Johnson KP; Panitch HS
    Md Med J; 1992 Jul; 41(7):601-3. PubMed ID: 1379317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological basis for the therapy of multiple sclerosis.
    Hohlfeld R
    Acta Neurol Belg; 1999 Mar; 99(1):40-3. PubMed ID: 10218091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
    Abb J; Deinhardt F; Zander H; Tenser RB; Rapp F; Goust JM; Fudenberg HH; Vilcek J; Ho M; Merigan TC; Oldstone MB; Jackson GG
    J Infect Dis; 1982 Jul; 146(1):109-15. PubMed ID: 6177805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results].
    Huber M
    Nervenarzt; 1988 Sep; 59(9):514-20. PubMed ID: 2460777
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologic effects of interferons: relevance to multiple sclerosis.
    Rudick RA; Ransohoff RM
    Mult Scler; 1995; 1 Suppl 1():S12-6. PubMed ID: 9345391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiology and treatment of multiple sclerosis].
    Itoyama Y
    Nihon Naika Gakkai Zasshi; 2001 Sep; 90(9):1827-32. PubMed ID: 11681067
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferons in multiple sclerosis].
    Milo R; Panitch H
    Harefuah; 1994 Apr; 126(8):451-8. PubMed ID: 7520880
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug treatment in multiple sclerosis--1995].
    Achiron A
    Harefuah; 1995 Dec; 129(12):579-83. PubMed ID: 8682363
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunological basis of current and novel therapies of multiple sclerosis.
    Dubois B; Opdenakker G
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):7-16. PubMed ID: 11729832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferons in neurology].
    Aguilar Rebolledo F
    Rev Invest Clin; 2000; 52(6):665-79. PubMed ID: 11256110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of interferon in multiple sclerosis.
    McFarlin DE
    Ann Neurol; 1985 Oct; 18(4):432-3. PubMed ID: 2416264
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nervous system diseases with immunologic disorders--present status of immunotherapy].
    Ono R; Hamaguchi K
    Nihon Naika Gakkai Zasshi; 1993 Jan; 82(1):122-6. PubMed ID: 7681462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon in multiple sclerosis.
    Hendel DL; Hart LL
    DICP; 1990 Feb; 24(2):158-60. PubMed ID: 1689920
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
    Wagstaff J; Scarffe JH; Crowther D
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.